Open for inclusion

VLX1570 and low-dose dexametasone in relapsed or replaised and refractory multiple myeloma: A clinical and correlative phase 1/2 study

Cancer type: Myeloma

Phase: I/II

Principal Investigator: Porkka Kimmo

Country: FI

Keywords: Finland, Helsinki, VLX1570

Status: Open for inclusion

Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02372240